🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 8 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/1973 | 0,0093 USD |
| 31/08/1973 | 0,0078 USD |
| 05/06/1973 | 0,0078 USD |
| 05/03/1973 | 0,0078 USD |
| 05/12/1972 | 0,0078 USD |
| 09/06/1972 | 0,0073 USD |
| 02/03/1972 | 0,0073 USD |
| 06/12/1971 | 0,0073 USD |
| 03/09/1971 | 0,0073 USD |
| 07/06/1971 | 0,0073 USD |
| 02/03/1971 | 0,0073 USD |
| 01/12/1970 | 0,0073 USD |
| 02/09/1970 | 0,0066 USD |
| 02/06/1970 | 0,0066 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/01/1999 | 71,45 | 72,16 | 71,45 | 71,92 | +0,67% | 1,00% | 4.596.528 |
| 04/01/1999 | 70,91 | 72,85 | 70,91 | 71,45 | +1,53% | 2,73% | 6.748.701 |
| 31/12/1998 | 70,85 | 71,15 | 69,90 | 70,37 | -0,88% | 1,77% | 3.232.032 |
| 30/12/1998 | 71,89 | 72,28 | 70,97 | 71,00 | -1,49% | 1,82% | 3.270.598 |
| 29/12/1998 | 70,31 | 72,19 | 69,81 | 72,07 | +2,07% | 3,39% | 4.005.875 |
| 28/12/1998 | 71,56 | 71,68 | 70,28 | 70,61 | -0,55% | 1,96% | 2.383.781 |
| 24/12/1998 | 71,68 | 71,68 | 70,58 | 71,00 | -0,54% | 1,54% | 1.301.826 |
| 23/12/1998 | 70,79 | 71,74 | 70,43 | 71,39 | +1,53% | 1,85% | 4.301.830 |
| 22/12/1998 | 69,30 | 70,82 | 68,82 | 70,31 | +2,30% | 2,88% | 4.918.054 |
| 21/12/1998 | 68,85 | 70,70 | 68,49 | 68,73 | -0,30% | 3,20% | 6.335.789 |
| 18/12/1998 | 70,61 | 70,61 | 68,85 | 68,94 | -2,32% | 2,49% | 8.661.301 |
| 17/12/1998 | 70,85 | 71,06 | 70,28 | 70,58 | +0,13% | 1,09% | 3.747.438 |
| 16/12/1998 | 69,60 | 70,97 | 69,60 | 70,49 | +1,29% | 1,97% | 5.554.610 |
| 15/12/1998 | 69,42 | 69,66 | 67,51 | 69,60 | +0,21% | 3,09% | 7.806.133 |
| 14/12/1998 | 69,36 | 70,19 | 69,18 | 69,45 | +0,00% | 1,46% | 7.663.605 |
| 11/12/1998 | 69,18 | 71,06 | 69,09 | 69,45 | -0,47% | 2,84% | 8.582.910 |
| 10/12/1998 | 70,40 | 71,33 | 69,15 | 69,78 | -3,74% | 3,09% | 16.709.731 |
| 09/12/1998 | 75,44 | 77,17 | 72,40 | 72,49 | -4,25% | 6,32% | 9.950.131 |
| 08/12/1998 | 74,43 | 75,86 | 74,37 | 75,71 | +0,63% | 2,00% | 5.067.709 |
| 07/12/1998 | 74,73 | 75,47 | 74,16 | 75,23 | +0,04% | 1,76% | 2.626.288 |
| 04/12/1998 | 73,86 | 75,26 | 73,86 | 75,20 | +1,78% | 1,90% | 3.631.739 |
| 03/12/1998 | 75,20 | 75,98 | 73,77 | 73,89 | -2,21% | 2,93% | 4.558.590 |
| 02/12/1998 | 74,28 | 75,74 | 73,71 | 75,56 | +0,88% | 2,73% | 5.191.792 |
| 01/12/1998 | 73,59 | 75,11 | 72,34 | 74,90 | +1,21% | 3,77% | 5.838.198 |
| 30/11/1998 | 75,38 | 75,38 | 73,80 | 74,01 | -2,36% | 2,10% | 4.741.152 |
| 27/11/1998 | 75,26 | 75,83 | 75,26 | 75,80 | +0,24% | 0,75% | 1.393.630 |
| 25/11/1998 | 75,68 | 76,07 | 75,08 | 75,62 | -0,08% | 1,30% | 4.473.283 |
| 24/11/1998 | 74,19 | 76,28 | 73,50 | 75,68 | +1,68% | 3,74% | 8.670.523 |
| 23/11/1998 | 72,34 | 74,49 | 72,19 | 74,43 | +2,97% | 3,17% | 5.164.544 |
| 20/11/1998 | 71,89 | 72,34 | 71,39 | 72,28 | +0,79% | 1,33% | 4.936.918 |